PROM1 and melanoma: ABCB5 mediates doxorubicin chemoresistance in human malignant melanoma, and is preferentially expressed on chemoresistant CD133-expressing tumor cells which indicates that this ABC transporter may be a marker of more primitive melanoma cells [22].